National AETC Support Center

François-Xavier Bagnoud Center

Rutgers School of Nursing
65 Bergen Street, 8th floor
Newark, NJ 07101
United States

Phone
(973) 972-5141
Fax
(973) 972-0397

The National AETC Support Center (NASC) provides training, technical assistance, and capacity-building resources of the AETC Program (8 regional centers, 2 national centers, the National HIV Curriculum, and special projects) to support the provision of timely, high-quality, state-of-the-science care of healthcare professionals working with existing and emerging populations affected by HIV. The NASC provides:

  • HIV training curricula
  • A virtual resource library
  • National AETC Program resource development
  • An AETC Program directory and event calendar
  • National AETC Program group coordination and collaboration
  • AETC Program marketing and communication services
  • Coordination and facilitation of the annual Ryan White HIV/AIDS Program Clinical Conference 
Principal Investigator
Phone: (973) 972-5141
Fax: (973) 972-0397
Program Director
Phone: (973) 972-6268
Fax: (973) 972-4263
Nurse Education Specialist
Phone: 973-972-8983
Multimedia Designer II

Resources: 36

Title Publish Date Sort ascending Review Date
Addressing the HIV Workforce Gap
Regional Champions: Building on Principles of Ending the HIV Epidemic
HIV Health Outcomes: It’s More Than Just Viral Suppression
The ABCs of Creating a Welcoming Clinic for Older Adults with HIV
Increasing Viral Suppression among People with HIV with Mental Health Disorders Infographic
Clinician Mobile Apps for HIV-related Care
HHS Adult ART Guidelines: Treatment-Experienced Patients
HHS Adult ART Guidelines: Initial Therapy
HIV Care Conversations
Stock Image Website and Resource List
Best Practices for Finding and Crediting Images
Stock Photo Library
Rapid (Immediate) ART Initiation & Restart: Guide for Clinicians
HIV Care Continuum: Key Resources for HIV Clinicians
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
Tips for Managing Digital Design Projects
U.S. Monkeypox (MPX) - Information and Recommendations
Community Health Worker Training Resources
Non-Occupational Post-Exposure Prophylaxis (nPEP) Toolkit
Prescribing PrEP: A Guide for Healthcare Providers
Reaching People with HIV in Rural United States
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Quick Guide: CDC HIV Laboratory Testing Recommendations
Federal COVID-19 Resources
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates
Conducting a Primary or Acute Care HIV Telemedicine Visit
HHS Adult ART Guidelines: HIV and ART in Older People
HIV Epidemic Rapid Response Toolkit
AETC Program Interprofessional Education (IPE) Toolkit
Evaluating AETC NCRC Partnerships for Impact
Hepatitis C: Getting Cured Is Easier than Ever
Flyer: Hepatitis C Screening and Treatment in People with HIV
Hep C Free Postcard
Passport to Cure
Resources for HRSA HAB Performance Measures
Resources for Accessibility

Articles: 35

Title Publish date Review date
Tissue Levels of TAF: Too Low for PrEP?
Switching from TDF/FTC to TAF/FTC
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA
HIV Meds Update - RAPID: Immediate ART Initiation
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Naltrexone Improves Virologic Suppression
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study
Immediate ART Initiation Improves Time to Viral Suppression
Bictegravir/TAF/FTC in Women
Bictegravir Approved for Initial ART, in Combination with TAF/FTC
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study
Dolutegravir + 3TC in Initial Therapy
Rapid ART Start
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine
Long-Acting Injectable ART: Cabotegravir + Rilpivirine
Safety of Dolutegravir at Conception: Updated Data
New ARV Approval - Fostemsavir
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine
HIV Meds Update: Anal Dysplasia Treatment Prevents Anal Cancer - The ANCHOR Study
HIV Meds Update: FDA Approves Lenacapavir, New Long-Acting Injectable ARV
HIV Meds Update: DoxyPEP – Doxycycline for STI Prevention
Updates on Mpox: Vaccination Efficacy and Spectrum of Disease in People with HIV
HIV Care Tools – A New Resource for Ending the HIV Epidemic
AETC Representation at the 2022 National Ryan White Conference on HIV Care & Treatment
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2022
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2023
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Use of Dolutegravir in Dialysis
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects
AETC Representation at the 2024 National Ryan White Conference on HIV Care & Treatment